Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004755 | Panoply™ Human EFNA2 Knockdown Stable Cell Line | Inquiry |
| CSC-DC004853 | Panoply™ Human ELF1 Knockdown Stable Cell Line | Inquiry |
| CSC-DC004874 | Panoply™ Human ELOF1 Knockdown Stable Cell Line | Inquiry |
| CSC-DC013950 | Panoply™ Human SEC24C Knockdown Stable Cell Line | Inquiry |
| CSC-SC004755 | Panoply™ Human EFNA2 Over-expressing Stable Cell Line | Inquiry |
| CSC-SC004853 | Panoply™ Human ELF1 Over-expressing Stable Cell Line | Inquiry |
| CSC-SC004874 | Panoply™ Human ELOF1 Over-expressing Stable Cell Line | Inquiry |
| CSC-SC013950 | Panoply™ Human SEC24C Over-expressing Stable Cell Line | Inquiry |
| CSC-RT1101 | Human ELOF1 Knockout Cell Line-HEK293T | Inquiry |
| CLKO-0591 | ELOF1 KO Cell Lysate-HEK293T | Inquiry |
| CSC-RT2671 | Human SEC24C Knockout Cell Line-Hela | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD05301Z | Human EFNA2 adenoviral particles | Inquiry |
| AD05406Z | Human Elf1 adenoviral particles | Inquiry |
| AD05426Z | Human ELOF1 adenoviral particles | Inquiry |
| AD14387Z | Human SEC24C adenoviral particles | Inquiry |
| LV11482L | human EFNA2 (NM_001405) lentivirus particles | Inquiry |
| LV11640L | human ELF1 (NM_172373) lentivirus particles | Inquiry |
| LV11641L | human ELF1 (NM_001145353) lentivirus particles | Inquiry |
| LV11668L | human ELOF1 (NM_032377) lentivirus particles | Inquiry |
| LV24917L | human SEC24C (NM_198597) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH031049 | shRNA set against Rat Elf1(NM_053520.2) | Inquiry |
| SHH031583 | shRNA set against Human ELOF1(NM_032377.3) | Inquiry |
| SHH031043 | shRNA set against Mouse Elf1(NM_007920.3) | Inquiry |
| SHW013967 | shRNA set against Danio rerio SEC24C (NM_001245968) | Inquiry |
| SHW005484 | shRNA set against Chicken EFNA2 (NM_204983) | Inquiry |
| SHW000358 | shRNA set against Chicken ELF1 (NM_001006269) | Inquiry |
| SHL029676 | shRNA set against Rat Spnb2(NM_001013130.1) | Inquiry |
| SHH416956 | shRNA set against Mouse Spnb2 (NM_009260.2) | Inquiry |
| SHH403836 | shRNA set against Rat SEC24C (NM_001109456.1) | Inquiry |
| SHH403832 | shRNA set against Mouse SEC24C (NM_172596.2) | Inquiry |
| SHH403828 | shRNA set against Human SEC24C (NM_004922.3) | Inquiry |
| SHH285237 | shRNA set against Mouse ELOF1 (NM_170777.3) | Inquiry |
| SHH285233 | shRNA set against Human ELOF1 (NM_032377.3) | Inquiry |
| SHH285001 | shRNA set against Rat Elf1 (NM_053520.2) | Inquiry |
| SHH284997 | shRNA set against Mouse Elf1 (NM_007920.3) | Inquiry |
| SHH283641 | shRNA set against Rat EFNA2 (NM_001168670.1) | Inquiry |
| SHH283637 | shRNA set against Mouse EFNA2 (NM_007909.3) | Inquiry |
| SHH283633 | shRNA set against Human EFNA2 (NM_001405.3) | Inquiry |
| SHH222252 | shRNA set against Mouse Spnb2(NM_009260.2) | Inquiry |
| SHH222234 | shRNA set against Mouse Spnb2(NM_175836.2) | Inquiry |
| SHH031565 | shRNA set against Mouse Elof1(NM_170777.3) | Inquiry |
| SHW014537 | shRNA set against Danio rerio EFNA2A (NM_131022) | Inquiry |
| SHW016587 | shRNA set against Danio rerio ELOF1 (NM_200386) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SKO0456 | ELOF1 Validated sgRNA vector | Inquiry |
| CDFH005843 | Human ELF1 cDNA Clone(NM_001145353.1) | Inquiry |
| CDFL012984 | Mouse Spnb2 cDNA Clone(NM_009260.2) | Inquiry |
| CDFL012985 | Mouse Spnb2 cDNA Clone(NM_175836.2) | Inquiry |
| CDFR008992 | Rat Sec24c cDNA Clone(NM_001109456.1) | Inquiry |
| CDFR009464 | Rat Elof1 cDNA Clone(NM_001126098.1) | Inquiry |
| CDFR013245 | Rat Elf1 cDNA Clone(NM_053520.2) | Inquiry |
| CDCR059812 | Mouse Elf1 ORF clone (NM_007920.3) | Inquiry |
| MiUTR1H-03189 | ELF1 miRNA 3'UTR clone | Inquiry |
| MiUTR1H-03205 | ELOF1 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-04355 | ELF1 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-04366 | ELOF1 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-11181 | SPNB2 miRNA 3'UTR clone | Inquiry |
| CDCB192073 | Rabbit ELF1 ORF clone (XM_008260024.1) | Inquiry |
| MiUTR1M-11182 | SPNB2 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-01708 | ELF1 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-02255 | ELF1 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-09030 | SEC24C miRNA 3'UTR clone | Inquiry |
| CDCB166959 | Chicken EFNA2 ORF Clone (NM_204983) | Inquiry |
| MiUTR3H-09031 | SEC24C miRNA 3'UTR clone | Inquiry |
| MiUTR4H-TG02985 | EFNA2 miRNA 3'UTR clone | Inquiry |
| CDCS418496 | Human ELOF1 ORF Clone (BC007516) | Inquiry |
| CDCS408494 | Human ELF1 ORF Clone (BC030507) | Inquiry |
| CDCR380162 | Rat Elf1 ORF Clone(NM_053520.2) | Inquiry |
| CDCB161833 | Chicken ELF1 ORF Clone (NM_001006269) | Inquiry |
| CDCB175442 | Danio rerio SEC24C ORF Clone (NM_001245968) | Inquiry |
| CDCB176012 | Danio rerio EFNA2A ORF Clone (NM_131022) | Inquiry |
| CDCB178062 | Danio rerio ELOF1 ORF Clone (NM_200386) | Inquiry |
| CDCB183401 | Rabbit SEC24C ORF clone (XM_008269947.1) | Inquiry |
| CDCH017071 | Human EFNA2 ORF clone(NM_001405.3) | Inquiry |
| CDCH078002 | Mouse Sec24c ORF clone (NM_001168273.1) | Inquiry |
| CDCL183998 | Mouse EFNA2 ORF clone(NM_007909.3) | Inquiry |
| CDCL183999 | Rat EFNA2 ORF clone(NM_001168670.1) | Inquiry |
| CDCR059808 | Human ELF1 ORF clone (NM_001145353.1) | Inquiry |
| CDCR059816 | Mouse Elof1 ORF clone (NM_170777.3) | Inquiry |
| CDCR059818 | Mouse Spnb2 ORF clone (NM_175836.2) | Inquiry |
| CDCR246861 | Mouse Spnb2 ORF Clone(NM_009260.2) | Inquiry |
| CDCR376039 | Rat Sec24c ORF Clone(NM_001109456.1) | Inquiry |
| CDCR376525 | Rat Elof1 ORF Clone(NM_001126098.1) | Inquiry |
| CDCS417825 | Human SEC24C ORF Clone (BC018928) | Inquiry |
| CDCB156287 | Cynomolgus ELOF1 ORF clone (NM_001190902.1) | Inquiry |
The ELF1 (E74-like factor 1) gene is a T cell-specific transcription factor in the Ets family, most representative of which has been found to be highly active in many human tumors. Ets (erythroblast transformation specific) gene is a type of oncogene composed of a series of highly conserved homologous sequences involved in the regulation of tumor invasion and metastasis. More than 20 members have been found.
Figure 1. The role of ELF1 in the development of lupus T cells. (Mak, et al. 2016)
Expression of ELF1 in Tumors
Breast cancer is the most common malignant tumor in women's life in developed countries. Kalet et al. found that ELF1 promotes breast cancer progression in four ERA (estrogen receptor A)-positive breast cancer cell lines. The proliferation, migration and invasion characteristics of ELF1 transcription factors were verified in MCF7 clonal cells. The growth rate of MCF7 tumor cells with high expression of ELF1 was significantly increased, while the control group was lower. Tumors with high expression of ELF1 showed a large central necrosis and increased apoptosis of apoptosis.
Pancreatic cancer is one of the ten common malignant tumors. It is difficult to find in the early stage. After the diagnosis is clear, it is most advanced and the prognosis is poor. Li et al. studied the role of ELF1 in epithelial-mesenchymal transition (EMT) and found that ELF1 gene expression was positively correlated with N-cadherin and negatively correlated with E-cadherin mRNA. To further study the role of ELF1, short hairpin constructs carrying ELF1 ribose acid (shRNA) expression of the green fluorescent protein, and the plasmid was transfected into pancreatic cancer cells. Studies have found that knocking out ELF1 in this pancreatic cancer cell line attenuates the effects of EMT. A decrease in cell migration and adhesion and a decrease in metastasis rate were observed in these cells, further indicating that the gene is involved in the development of pancreatic cancer.
RhoC is a member of the Rho family of Ras superfamily homologous gene families and has been shown to be involved in tumorigenesis and tumor progression. Hepatitis B virus proteins play an important role in the development and progression of hepatocellular carcinoma (HCC). Qin et al. have shown that high expression of ELF1 up-regulates RhoC promoter activity and mRNA and protein levels. Hepatitis B virus-adenovirus recombinant virus infection can lead to up-regulation of ELF1, which in turn leads to tumorigenesis.
ELF1 Promotes Tumorigenesis and Development
Survivin is the strongest inhibitor of apoptosis in the current inhibitor of apoptosis protein (IAP). It has been reported that the expression of ELF1 in non-small cell lung cancer is positively correlated with survivin. The researchers used immunohistochemistry and in situ end labeling (TUNEL) to demonstrate that ELF1 expression was negatively correlated with tumor cell apoptosis in non-small cell lung cancer tissues. The degradation of most regulatory proteins in eukaryotic cells is through the ubiquitin-proteasome pathway, which regulates the ubiquitin-proteasome pathway and regulates cell apoptosis and growth.
Ki-67 antigen is involved in cell division and proliferation. The marker index of Ki-67 can reliably and rapidly reflect the proliferation rate of malignant tumors, which is related to the development, metastasis, and prognosis of various malignant tumors. Kong et al. used tissue microarray and immunohistochemistry to find that the expression of ELF1 and Ki-67 protein in 64 lung cancer tissues was significantly higher than that in 10 normal lung tissues, and the expression level was related to tumor differentiation, clinical stage, and lymph node metastasis. At the same time, it was found that ELF1 was positively correlated with Ki-67 expression. Subsequently, Furlan et al also found a positive correlation between the ratio of Etf-1 and Ki67-positive cells in breast cancer tumorigenic models, which promoted tumor growth and inhibited tumor growth and metastasis after knocking out the gene. Studies have shown that Etf-1 expression is associated with cancer invasion and prognosis.
References: